KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Gilead Sciences (GILD) Long-Term Deferred Tax (2016 - 2025)

Historic Long-Term Deferred Tax for Gilead Sciences (GILD) over the last 11 years, with Q3 2025 value amounting to $2.0 billion.

Gilead Sciences' Long-Term Deferred Tax changed N/A to $2.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 billion, marking a year-over-year change of. This contributed to the annual value of $2.4 billion for FY2024, which is N/A changed from last year.
Latest data reveals that Gilead Sciences reported Long-Term Deferred Tax of $2.0 billion as of Q3 2025.
In the past 5 years, Gilead Sciences' Long-Term Deferred Tax ranged from a high of $2.7 billion in Q2 2025 and a low of $2.0 billion during Q3 2025